The ability to detect skin cancer, the leading type of cancer, early could save lives, and the American Cancer Society recently shared information on how to spot skin cancer in the beginning stages when it is easily treatable and has not advanced.

Pfizer said its drug tafamidis, an investigational treatment for transthyretin cardiomyopathy (TTR-CM), a rare, fata disease linked to progressive heart failure, has been granted U.S. Food and Drug Administration (FDA) fast track designation.

University of California San Diego School of Medicine said it has agreed to a five-year partnership with Janssen Pharmaceuticals, a division of the Janssen Pharmaceutical Companies of Johnson & Johnson, to research treatments for metabolic diseases.

AstraZeneca and its global biologics research and development arm, MedImmune, said the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Imfinzi (durvalumab).

Breast cancer patients who receive even a single chemotherapy treatment can experience a major impact on their walking gait and balance, boosting their fall risk, according to a recent study conducted by the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James).

Eli Lilly and Co. said three of its Phase 3 studies of galcanezumab, an investigational treatment to prevent episodic and chronic migraines, have found that galcanezumab significantly reduces the amount of migraine headache days experienced by sufferers.

Novartis said it will collaborate with IBM Watson Health on an initiative that will combine Novartis’ expertise in breast cancer with Watson’s data analytics and machine learning to advance cancer care and boost patient outcomes.

Novartis said it presented its latest data on oncology at the recent 53rd annual meeting of the American Society of Clinical Oncology in Chicago.

Novartis said in a release that expanded use of Zykadia to include the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive has been recommended by the the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP).

The American College of Cardiology, the American Heart Association (AHA) and the Heart Failure Society of America have released a second update to a guideline for heart failure management, AHA said in a release.

The American Academy of Physicians Assistants (AAPA) and CancerLinQ are teaming up to advance research in cancer care, a release on the American Society of Clinical Oncology website said.

Proposed changes for the Medicare Advantage and Part D drug programs for 2018 were recently released by the Centers for Medicare & Medicaid Services (CMS).

Abide Therapeutics said it has commenced dosing in a Phase 1 study utilizing functional magnetic resonance imaging (fMRI) to examine patterns of neurological activity linked to oral administration of ABX-1431, a first-in-class investigational monoacylglycerol lipase (MGLL) inhibitor that controls the activity of the endocannabinoid neurotransmitter system, Abide said in a press release.

Apricus Biosciences said that the Vitaros drug-device combination human factor testing study required by the Food and Drug Administration (FDA) has begun.

Biocept., a commercial provider of clinically actionable liquid biopsy tests for cancer patients, said it will work with the Addario Lung Cancer Medical Institute (ALCMI) on a clinical collaboration and initiation of the landmark ALCMI-009 liquid biopsy clinical trial, Biocept said in a press release.

Biotechnology company Shire said it highlighted its research results on the unmet and changing needs of adults affected by attention-deficit/hyperactivity disorder (ADHD) at the annual meeting of the American Psychiatric Association (APA) held earlier this month in San Diego.

Ireland-based Mainstay Medical International plc has begun commercialization for and made its first sale and implantation of ReActiv8, an implantable restorative neurostimulation system that treats chronic low back pain, Mainstay said in a press release.

K2M Group Holdings Inc., a medical device company that designs and develops spine and minimally invasive solutions, highlighted its Balance ACS platform to aid surgeons at the 2017 combined meeting of the European Paediatric Orthopaedic Society and the Pediatric Orthopaedic Society of North America (EPOSNA) on May 3-6 in Barcelona, Spain.

AIDS Alliance for Women, Infants, Children, Youth & Families (AIDS Alliance), an affiliate of The AIDS Institute, joined Advocates for Youth to address how HIV/AIDS impacts young people and how they have contributed to the fight against HIV/AIDS in the U.S. as part of National Youth HIV/AIDS Awareness Day (NYHAAD) the Aids Institute said in a press release.

The American Heart Association said a 40-year study in its journal, Circulation, found that middle-age individuals with good heart health live longer, have less chronic diseases in later years and remain healthier longer than other individuals.